Rapid Radiotherapy Technique Shows Promise in First Human Trial FLASH relieved pain in most patients with bone metastases, with few side effects Oct 24, 2022
High-Dose-Rate Brachytherapy Boost in Prostate Cancer Improves QOL Patients report better urinary and bowel function outcomes Oct 24, 2022
Tumor Volume-Adapted RT Leads to Good Lung Cancer Control With Low Toxicity No recurrence at 1 year in 90% of cases with primary tumors, metastases, synchronous disease Nov 02, 2021
Primary RT Fares Well in Abbreviated Trial for HPV Oropharyngeal Cancer No deaths, progression with RT after early termination because of deaths in surgery arm Oct 29, 2021
Mixed Results With RT Plus Short-Term ADT in Intermediate-Risk Prostate Cancer No survival benefit, but risk of biochemical failure, metastasis, cancer death improved Oct 28, 2021
Meta-Analysis Reaffirms Role of ADT With Radiotherapy in Prostate Cancer Prolonged adjuvant ADT also improved survival Oct 27, 2021
Extended-Field RT Boosts Survival in Locally Advanced Cervical Cancer Double-digit improvements in OS, DFS, extrapelvic control in well-selected patients Oct 27, 2021
Gentler Adjuvant RT Could Be Viable for Some HPV-Positive Oral Cancers Those with extranodal extension didn't fare as well Oct 27, 2021
Gene Test Finds Gradations in High-Risk Prostate Cancer Study of untreated cancers prognostic for metastasis, cancer mortality, overall survival Oct 26, 2021
No Survival Benefit for Internal Mammary Node Irradiation in Breast Cancer Women with medially or centrally located tumors may be candidates, however, says researcher Oct 26, 2021
Potential New Standard for Post-Prostatectomy Radiotherapy Side effects at 2 years similar with hypofractionated versus conventional RT Oct 25, 2021
Targeted RT Boosts PFS in Oligoprogressive Lung Cancer Fivefold improvement in NSCLC but no benefit in oligoprogressive breast cancer Oct 25, 2021
More Evidence for Safety of Accelerated Radiation in Early Breast Cancer Studies show low toxicity with few recurrences Oct 25, 2021
Focal RT Boost in High-Risk Prostate Cancer Cuts PSA Relapse Rates of biochemical relapse cut in half with boost to 95 Gy Oct 29, 2020
High-Dose SBRT More Effective for Painful Spine Metastases Roughly one-third of patients had a complete pain response at 3 and 6 months Oct 26, 2020
ASTRO Unveils First RT Guideline for Pancreatic Cancer Radiation's role in pancreatic cancer is "controversial," says guideline author Sep 23, 2019
Tx Deintensification Wins in Head and Neck Cancer, But ... Only against another less-intensive approach in HPV-positive disease Sep 18, 2019
Post-Immunotherapy SBRT Boosts Outcomes in Advanced NSCLC Increased systemic response rate, disease control rate, and PFS in phase II trial Sep 17, 2019
Consider PSA Before Adding ADT to Salvage Radiation Men with levels below 0.6 ng/mL show no benefit, at risk of other-cause mortality Sep 16, 2019
Hippocampus-Sparing Radiation a New Option in Brain Mets Patients Approach preserved cognitive function, but patient prognosis a key consideration Oct 24, 2018
Black Race Not Associated with Worse Prostate Ca Outcomes Results contrast with past population registry data Oct 24, 2018
SABR Equally Effective in RCC Patients With One or Both Kidneys Minimal side effects reported with high-dose treatment Oct 23, 2018
Cetuximab Fails Twice vs Cisplatin for HPV-Related Oral Ca Cetuximab resulted in more patient deaths across U.S., German studies Oct 23, 2018
Liquid Biopsy Rules Out Relapse in HPV-Positive Oral Ca Test had 100% negative predictive value Oct 23, 2018
Nearly 90% Free of Prostate Ca Progression With ADT, Pelvic Node RT Data also showed trend toward reduction in distant metastases Oct 22, 2018
Aggressive RT, Surgery Doubles OS in NSCLC With Limited Mets If new drug produced such a response it would make "millions," said expert Oct 22, 2018
No Increase in Late Effects With Weekly RT in Breast Ca 10-year data show low rate of late-onset effects with 28.5 Gy regimen Oct 21, 2018
RT Add-On Boosts Outcomes in 'Low-Risk' DCIS Breast Ca Highest benefit seen in patients who also used tamoxifen Oct 21, 2018
SBRT Doubles 5-Year Survival in Oligometastatic Cancers Most patients in phase II trial had up to three metastatic lesions Oct 17, 2018
